RE: can someone quantify....7 Jun 2018 12:18
The other problem with abiraterone is that not only does it cost upwards of �40,000 per patient year, and it does have marked side effects...it only palliates for about 18 months...as my friend has just proved. His PSA was reduced for about 15 months and now it has started its upward rise again...and he is getting thinner by the day. He has stoppped abiraterone and is now back on enzilutamib I think. I don't suppose Val 201 was offered although he is being treated in London at...I think...UCL. I keep on hoping that they will suddenly announce a "stop the trial " moment...